{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:48Z","timestamp":1759336488853},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The association between free triiodothyronine (FT3) and long-term prognosis in dilated cardiomyopathy (DCM) patients has not been evaluated. The purpose of this study was to determine whether the level of FT3 could provide prognostic value in patients with DCM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data of consecutive patients diagnosed with DCM were collected from October 2009 to December 2014. FT3 was measured by fluoroimmunoassay. Other biochemical markers, such as free thyroxin (FT4), thyroid-stimulating hormone, red blood cell, hemoglobin, blood urea nitrogen, and serum creatinine, were tested at the same time. Follow-up was performed every 3 months. The primary endpoint was all-cause mortality. Pearson analysis was used to evaluate the correlation of FT3 and other lab metrics with DCM patients\u2019 prognosis. The association of long-term mortality in DCM and FT3 was compared using Cox hazards model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Data of 176 patients diagnosed with DCM were collected. Of them, 24 patients missed FT3 values and six patients were lost to follow-up. Altogether, data of 146 patients were analyzed. During the median follow-up time of 79.9 (53.5\u2013159.6) months, nine patients lost, 61 patients died (non-survival group), and 85 patients survived (survival group). FT3 was significantly lower in non-survival group than that in survival group (3.65\u200a\u00b1\u200a0.83 pmol\/L <jats:italic toggle=\"yes\">vs.<\/jats:italic> 4.36\u200a\u00b1\u200a1.91 pmol\/L; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.003). FT3 also showed a significantly positive correlation with red blood cell and hemoglobin, negatively correlated with age, blood urea nitrogen and serum creatinine (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.05), respectively. Patients in the group of lower FT3 levels (FT3 \u22643.49 pmol\/L) suffered from a higher risk of all-cause mortality (<jats:italic toggle=\"yes\">P<\/jats:italic> for log-rank\u200a=\u200a0.001). In multivariate Cox regression analysis, FT3 level was significantly associated with all-cause mortality (hazard ratio: 0.70, 95% confidence interval 0.52\u20130.95, <jats:italic toggle=\"yes\">P<\/jats:italic> for trend\u200a=\u200a0.021).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Low levels of FT3 were associated with increased all-cause mortality in patients with DCM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000000896","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:03:26Z","timestamp":1593529406000},"page":"2170-2176","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy"],"prefix":"10.1097","volume":"133","author":[{"given":"Hong-Yan","family":"Zhao","sequence":"first","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Qian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Shi","family":"Chen","sequence":"additional","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Bilaal","family":"Toorabally","sequence":"additional","affiliation":[{"name":"Victoria Hospital, Candos, Mauritius"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Guang","family":"Chen","sequence":"additional","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China"},{"name":"Department of Cardiology, Qinghai Province Hospital, Xining, Qinghai 810007, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"key":"R1-20230813","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"R2-20230813","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"R3-20230813","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230813","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R5-20230813","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCHEARTFAILURE.114.001896","article-title":"Population risk prediction models for incident heart failure: a systematic review","volume":"8","author":"Echouffo-Tcheugui","year":"2015","journal-title":"Circ Heart Fail"},{"key":"R6-20230813","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1210\/jc.2015-2480","article-title":"Normal thyroid function and the risk of atrial fibrillation: the Rotterdam study","volume":"100","author":"Chaker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20230813","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cpcardiol.2015.04.002","article-title":"Thyroid disease and the heart","volume":"41","author":"Klein","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"R8-20230813","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0735-1097(90)90462-X","article-title":"Altered thyroid hormone metabolism in advanced heart failure","volume":"16","author":"Hamilton","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R9-20230813","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"R10-20230813","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archinte.167.9.928","article-title":"Association between serum free thyroxine concentration and atrial fibrillation","volume":"167","author":"Gammage","year":"2007","journal-title":"Arch Intern Med"},{"key":"R11-20230813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM198201073060107","article-title":"Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones","volume":"306","author":"Larsen","year":"1982","journal-title":"N Engl J Med"},{"key":"R12-20230813","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10741-016-9545-8","article-title":"Cardioprotection and thyroid hormones","volume":"21","author":"Pingitore","year":"2016","journal-title":"Heart Fail Rev"},{"key":"R13-20230813","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11897-017-0312-5","article-title":"Thyroid dysfunction and heart failure: mechanisms and associations","volume":"14","author":"Vargas-Uricoechea","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"R14-20230813","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R15-20230813","doi-asserted-by":"crossref","first-page":"e0190987","DOI":"10.1371\/journal.pone.0190987","article-title":"Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis","volume":"13","author":"Gil-Cayuela","year":"2018","journal-title":"PLoS One"},{"key":"R16-20230813","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/clc.22858","article-title":"Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy","volume":"41","author":"Zhang","year":"2018","journal-title":"Clin Cardiol"},{"key":"R17-20230813","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"R18-20230813","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","article-title":"Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy","volume":"20","author":"Mestroni","year":"1999","journal-title":"Eur Heart J"},{"key":"R19-20230813","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"R20-20230813","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"R21-20230813","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/CIRCULATIONAHA.105.572883","article-title":"Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction","volume":"112","author":"Tang","year":"2005","journal-title":"Circulation"},{"key":"R22-20230813","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-008-9126-6","article-title":"The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence","volume":"15","author":"Galli","year":"2010","journal-title":"Heart Fail Rev"},{"key":"R23-20230813","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1210\/jc.2014-4159","article-title":"Thyroid status, cardiac function, and mortality in patients with idiopathic dilated cardiomyopathy","volume":"100","author":"Wang","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20230813","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejheart.2004.04.016","article-title":"Relation between free triiodothyronine\/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy","volume":"7","author":"Kozdag","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R25-20230813","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/01.CIR.87.5.1435","article-title":"The thyroid and the heart","volume":"87","author":"Polikar","year":"1993","journal-title":"Circulation"},{"key":"R26-20230813","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"R27-20230813","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"key":"R28-20230813","doi-asserted-by":"crossref","first-page":"e6094","DOI":"10.1097\/MD.0000000000006094","article-title":"Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T09:01:26Z","timestamp":1691917286000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":28,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000896","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}